abstract |
The subject of the present invention is a polypeptide represented by the formula: NLC, in which: N represents the amino acid sequence 25-81 of gp41, C represents the amino acid sequence 112-157 of gp41, and L represents a flexible binding sequence comprising from 2 to 30 amino acids, as well as its use for immunization against HIV-related infection. |